SUMMARY -Pleomorphic adenoma is rarely seen in childhood. After detailed literature search, we did not come across a case of frequent relapse of this benign tumor from childhood to adulthood. Th e World Health Organization defi nes relapse of pleomorphic adenoma as a histologically benign tumor that can have local or distant metastasis. Th ere is one hypothesis how benign tumor can metastasize. According to this hypothesis, probably during the fi rst operative procedure the tissue around the tumor becomes permeable for tumor cells, which can lead to implantation of tumor cells into the surrounding tissue. In this case report, we present a case of a 30-year-old woman with pleomorphic adenoma of the submandibular gland, which relapsed three times. Th e patient was fi rst operated on in 1993, at the age of 7 years. Th e fi rst two relapses occurred in 1998 and 2001, at the age of 12 and 15, respectively. Th e last relapse occurred in 2015, at the age of 29 years. All relapses were localized in the submandibular region on the right side of the neck, where the primary tumor had been operated on.
Introduction
Tumors of salivary glands account for 1%-4% of all neoplastic tumors in humans. Th ese tumors are very rare in childhood but 35% of them are malignant. Th e most frequently seen tumor of salivary glands is pleomorphic adenoma that generally has an abundant amount of connective tissue and is therefore also named mixed tumor.
Th ese tumors are classifi ed as semi-malignant to make clinicians aware of their potential malignant behavior. Th eir multilocular structure, with fi ngerlike elongations, is a reason for possible tumor penetration into the surrounding tissue [1] [2] [3] [4] . Th e other group of tumors of salivary glands is metastatic pleomorphic adenoma (MPA) that, up to day, is still an unsolved entity. It is a histologically benign tumor which may give local and distant metastasis. Th e most frequent site of MPA is parotid gland (74%), then small salivary glands (16%) and submandibular gland (10%). In the history of the disease, the majority of patients (81%) have at least one relapse before encountering distant metastasis. Bones are most frequently involved with metastasis (45%), followed by lungs (36%) and internal organs (10%). In the head and neck region, lymph nodes may be aff ected in 17% of cases. After the initial treatment of benign pleomorphic adenoma, MPA develops in 5 years on average, although metastases have been described 16, 30, or even 50 years after the fi rst operation. According to some authors, the rate of 5-year disease-free period for MPA is 58% 5, 6 . Nowadays, it is not possible to predict which benign pleomorphic adenoma has metastatic potential. Th e use of positron emission tomography (PET) scan to defi ne distant metastasis or immunohistologic analysis used to predict the possible occurrence of metastasis did not yield relevant clinical data due to the small number of patients [5] [6] [7] [8] . For this reason, MPA is still considered as a consequence of inadequate fi rst operation. When enucleation of the tumor was the preferred surgical approach, relapses were diagnosed in 20%-45% of cases 9 . Adjuvant radiotherapy and chemotherapy as preventive measures for possible relapse of the disease did not prove successful, and surgical treatment remains the fi rst option in the treatment of MPA 10 . Th e paradoxical nature of MPA with its benign histologic characteristics and ability to give metastasis intrigues clinicians all over the world. Th ere are few hypotheses why a benign tumor may give metastasis. One of them is the implantation hypothesis according to which blood and lymph vessels become permeable for tumor cells, which then enter the surrounding tissue. However, metastasis of pleomorphic adenoma found in bones and internal organs, without a history of previous operation of salivary glands beat the implantation theory. Distant metastases are explained by the ability of MPA to mutate the previously accumulated genetic potential. Current diagnostic methods cannot classify pleomorphic adenoma or identify which benign pleomorphic adenoma has a metastatic potential. Good patient history is the basis to suspect relapse in a patient who was treated for pleomorphic adenoma [11] [12] [13] .
Case Report
In this case report, we present a 30-year-old woman who had 3 relapses of pleomorphic adenoma. In 1993, at the age of 7 years, pleomorphic adenoma of the right submandibular gland was diagnosed. Extirpation of the whole gland with the tumor was performed. Histopathologic report revealed pleomorphic adenoma, which was removed completely. Th e fi rst relapse occurred in 1998, i.e. 5 years after the fi rst operation, in the region of surgical scar, where a nodule of 1 cm in size appeared. Cytologic report revealed pleomorphic adenoma. Selective supraomohyoid dissection of the neck was per- formed. Histologic examination confi rmed the nodule to be pleomorphic adenoma.
Th e second relapse occurred in 2001. At 1 cm deep to the incisional scar from the previous surgical procedure, a single subcutaneous nodule was found. In the neck region I and II, excision of the scar and surrounding tissue including the subcutaneous nodule was performed. Histologic examination confi rmed the nodule to be pleomorphic adenoma. During the next 5 years, the patient was regularly followed-up. Besides ultrasonographic examination of the neck, abdominal organs were also examined by ultrasound.
Th e third relapse occurred in 2012. Th e patient noticed a new nodule in the scar but came to the hospital three years later, in 2015. In the region of the scar, a few nodules were present, all of them solid in consistency and partially fi xed. Th e biggest nodule was 1.5 cm in diameter. Contrast computed tomography (CT) of the neck region revealed a few inhomogeneous nodules, 0.9-1.4 cm in diameter, in the right submandibular region (Fig. 1) .
Cytological puncture confi rmed the metastasis of pleomorphic adenoma. Including the scars, wide reexcision of the neck region I and II was performed. Macroscopically, four oval, well-formed, white nodules were found in the subcutaneous tissue. Th e size of the biggest nodule was 2.5 cm in diameter. Histologic examination confi rmed pleomorphic adenoma in all four nodules (Figs. 2 and 3 ). Ultrasound examination of the abdominal organs and x-ray of the lungs were normal.
Discussion
Pleomorphic adenoma with metastasis is a rare clinical entity, characterized by the presence of one or more histologically benign tumors outside the salivary gland. In the majority of cases, metastases are reported in patients that were previously operated on due to pleomorphic adenoma [5] [6] [7] . Good patient history is inevitable to suspect the possible metastases related to pleomorphic adenoma. Th e fi rst relapse can be explained by the surgical method used. As mentioned before, in cases of macroscopically well-defi ned tumors, enuclation was the surgical procedure of choice 9 . Finger-like extensions of pleomorphic adenoma, which are not removed during surgical procedure, are the most probable reason for relapse. As surgical techniques have improved, enuclation technique has been replaced with superfi cial parotidectomy as a minimal surgical approach in removing pleomorphic adenoma [15] [16] [17] . During superfi cial parotidectomy as a surgical treatment of pleomorphic adenoma relapse, the tumor must be removed according to the accepted oncologic principles. Even then, the risk of relapse of the tumor cannot be excluded. It is explained by the hypothesis according to which substances excreted by the tumor can increase permeability of the surrounding blood and lymph vessels. During surgical procedure, manipulation of the tumor tissue may cause tumor cells to enter the blood and lymph vessels [5] [6] [7] [8] . Th is hypothesis could explain the occurrence of local, as well as distant metastasis of this tumor that is benign in nature. In spite of this logical explanation, there are reports of patients where metastases of pleomorphic adenoma were found in bones and/or internal organs, although primary tumor had not been operated on or was found after encountering metastases. Th ese cases were explained by the hypothesis according to which pleomorphic adenoma could genetically mutate its genetic potential [11] [12] [13] [14] . Current diagnostic methods cannot predict/defi ne which benign pleomorphic adenoma shows aggressive component that can lead to development of metastasis. Numerous immunohistologic techniques have been used in an attempt to solve the unpredictable nature of pleomorphic adenoma, e.g., Ki-67, p53, p16, bci-2. Th ese immunohistologic techniques are highly immune reactive in cases of malignant tumors of salivary glands [18] [19] [20] [21] . Due to the small number of tissue specimens taken, immunohistologic analysis done in order to predict the possible malignant nature of pleomorphic adenoma did not give satisfactory results. Th erefore, results of this procedure should be taken with caution. Analysis of a greater number of specimens may help understand the biological mechanisms and genetic mutations that take part in the malignant nature of benign pleomorphic adenoma. In spite of the achievements in modern medicine, patient history remains a mainstay in the diagnosis of MPA 22, 23 . It is an open question whether to tell the patient, especially children and their parents, about the unpredictable nature of the tumor or to tell about it when the relapse occurs. Is it necessary to make the patient live with this fear for life? How long should the patient be followed-up? Although in our practice we had just one patient with MPA, we fi nd it worth mentioning since it was a case of a child that had to grow up with that disease. Nowadays, the majority of patients are very well selfinformed about their disease; subsequently, according to our opinion, there is no need to tell the patient with benign pleomorphic adenoma about the possible relapses, which are anyhow diffi cult to predict. Th e patient should be informed about the nature of pleomorphic adenoma in case of proved relapse. Th e benign nature of the disease should be pointed out. Further, it is diffi cult to defi ne the time-line for follow up checkups since relapse can occur many years after the fi rst surgery. Individual approach to the patient, as well as patient age and location of relapse should be taken in consideration.
Conclusion
In childhood, the occurrence of pleomorphic adenoma is rare and relapses are really unique cases. Here, we present a case of pleomorphic adenoma of the submandibular gland that relapsed three times over 18 years of the initial diagnosis. Except for good patient history, to date there is no proved medical approach to predict the possible relapse and its prevention. In the case of relapse of pleomorphic adenoma, the treatment of choice is surgery. Th e nature of the disease brings a dilemma whether to warn the patient about the possibility of the disease relapse or the patient should be told that he/she is completely cured.
According to our opinion, in such cases, the approach to the patient should be individualized. Th e unpredictable nature of pleomorphic adenoma and the possibility of relapse should only be explained to patients that experience relapse of the disease.
